Valuing Health Technologies at NICE

Recommendations for Improved Incorporation of Treatment Value in HTA

Dana P. Goldman, Darius N. Lakdawalla, Tomas Philipson, Wesley Yin

ResearchPosted on rand.org 2010Published in: Health Economics, v. 19, no. 10, Oct. 2010, Editorial, p. 1109-1116

The method currently used to value new health-care treatments in the UK does not adequately capture some dimensions of the full costs and benefits of those treatments to the citizenry supporting the National Health Service.

Topics

Document Details

  • Availability: Non-RAND
  • Year: 2010
  • Pages: 8
  • DOI: https://doi.org/10.7249/pubs
  • Document Number: EP-201000-127

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.